Skip to Content

Join the 'Ferric Citrate' group to help and get support from people like you.

Ferric Citrate News

FDA Approves Auryxia (ferric citrate) Tablets as a Treatment for People with Iron Deficiency Anemia and Chronic Kidney Disease, Not on Dialysis

Posted 13 Nov 2017 by Drugs.com

BOSTON, Nov. 07, 2017 (GLOBE NEWSWIRE) – Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX), a company focused on bringing innovative medicines to people with kidney disease, today announced that the U.S. Food and Drug Administration (FDA) has approved Auryxia for an additional indication. The approval is for the treatment of iron deficiency anemia in adults with chronic kidney disease (CKD), not on ...

Keryx Biopharmaceuticals Announces Trade Name Auryxia for Ferric Citrate

Posted 17 Nov 2014 by Drugs.com

NEW YORK, Nov. 17, 2014 (GLOBE NEWSWIRE) – Keryx Biopharmaceuticals, Inc., a biopharmaceutical company focused on bringing innovative therapies to market for patients with renal disease, today announced that the U.S. Food and Drug Administration (FDA) has approved the trade name Auryxia (ferric citrate) for its FDA-approved ferric citrate. Auryxia, an iron-based phosphate binder, was approved by ...

Ask a Question

Further Information

Related Condition Support Groups

Hyperphosphatemia of Renal Failure, Iron Deficiency Anemia

Related Drug Support Groups

Auryxia

Ferric Citrate Patient Information at Drugs.com